Unique subset of thymic epithelial cells defined by the expression of a novel neuroendocrine antigen.
Sobol. R E RE; Burton. D D; Schaeffer. M T MT; Tice. D D; Royston. I I; Deftos. L J LJ
Key Findings
- A 62‑69 kDa antigen was found on specific thymic epithelial, splenic reticular, pituitary and thyroid neuroendocrine cells.
- The antigen is recognized by a new monoclonal antibody (1D4) but not by thymosin‑alpha‑1 antisera or the A2B5 antibody.
- The 1D4+ cells represent a distinct subset of medullary thymic epithelial cells, suggesting a new neuroendocrine‑immune link.
Practical Outcomes
- There are no direct actions or dosage recommendations for biohackers. The findings are purely mechanistic and may only become useful if future research links this antigen to health or disease.
Summary
The paper describes a basic science discovery of a new protein marker on certain immune and neuroendocrine cells, but it doesn’t test thymosin‑alpha‑1 or give any tips you can use right now.
Abstract
Murine monoclonal antibodies (MoAbs) were produced against a rat medullary thyroid carcinoma to identify neuroendocrine differentiation antigens. One of these antibodies (1D4) identified a novel 62- to 69-kDa antigen expressed by subsets of immune system epithelial and neuroendocrine cells. This antigen is expressed by distinct subsets of thymic epithelial and splenic reticular cells and is shared by discrete subsets of anterior pituitary and thyroid neuroendocrine cells. In the thymus, 1D4 expression identified a unique subset of stellate-shaped Ia+ medullary epithelial cells which did not react with thymosin alpha-1 antisera nor with the MoAb A2B5 specific for a GQ ganglioside expressed by thymic hormone-producing cells. The availability of the 1D4 MoAb should facilitate further characterization of 1D4+ immune system epithelial cells and may advance our understanding of neuroendocrine-immune system interactions.
Study Information
pubmed
1988
1988-08-01T00:00:00.000Z
10.1016/0008-8749(88)90167-0
7
19